Metraipolis › archive › dc_d7733d35fb7e
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis — Europe PMC PMID:41425831
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41425831
- DOI
- 10.1136/bmjno-2025-001210
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T14:46:09.465Z
- SHA-256 of the archived text
66740106d7952d6b397848fdea57e51ed97b721e3d1ff7f730e0d354ed9cb2df- Stable URL of this page
https://metraipolis.com/documento/dc_d7733d35fb7e
How to cite
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis — Europe PMC PMID:41425831 — Europe PMC (en), https://europepmc.org/article/MED/41425831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7733d35fb7e (Metraipolis archive dc_d7733d35fb7e, sha256 66740106d7952d6b397848fdea57e51ed97b721e3d1ff7f730e0d354ed9cb2df)
BibTeX
@misc{dcd7733d35fb7e,
title = {Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis — Europe PMC PMID:41425831},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41425831},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7733d35fb7e; sha256 66740106d7952d6b397848fdea57e51ed97b721e3d1ff7f730e0d354ed9cb2df},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41425831. Agents can read the archived copy with the MCP tool read_document.